Inclusion Criteria:  The patients will be enrolled in the study if they have:  Non-segmental vitiligo Stable disease (a patient reporting no new lesions, no progression of existing lesions, and absence of Koebner phenomenon during the past 1 year)  Exclusion Criteria:  History of skin cancers, keloid, hypertrophic scars or photosensitivity. Use of any topical medications, phototherapy, or laser for vitiligo within 1 month prior to enrollment. Renal, hepatic, hematological or debilitating chronic diseases. Active inflammation or infection at site of treatment. Pregnant and lactating females. Age under 18 years old. Segmental vitiligo, active or extensive disease. Unrealistic expectation.